Aperture Therapeutics
Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodegeneration. The company's innovative platform leverages insight into disease resilience from large genomic and clinical data with streamlined drug discovery platform that generates drugs mimicking the effects of protective human gene variants.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Aperture Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- AV
Arventh V.
() · Other
EmailPhone - ES
Ekaterina Stomakhina
Nine Square Therapeutics · Other
EmailPhone - MJ
Martin Jacko
Chief Executive Officer · Other
EmailPhone - TD
Therése Dalebrant
Chief of Staff · Operations
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Aperture Therapeutics
4 distinct titles indexed · top 4 shown.
- 1()
- 1chief executive officer
- 1chief of staff
- 1nine square therapeutics
Sign up to unlock all 5 contacts at Aperture Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Aperture Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.